12:00 AM
 | 
May 01, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

Ariad Regulated Gene Expression Technology regulatory update

ARIA received U.S. Patent No. 6,054,436 covering methods for controlling the survival of genetically engineered hematopoietic cells...

Read the full 62 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >